PEDIATRIC ONCOLOGY

PEDIATRIC ONCOLOGY

Current statistics report that more and more children recover about 70% of children with cancer today heals. In order to improve these results, very good but not satisfactory, assumes considerable importance detailed knowledge of the biology of pediatric cancer and it becomes crucial to have new drugs more effective than those currently available as well as all necessary equipment for cancer prophylaxis.
Since this is in fact very rare diseases, medications available for these tumors are limited, and many public facilities are not sufficiently equipped with equipment suitable for all series.
Fondazione Ginevra Caltagirone finding the real needs has set itself the objective to support pediatric oncology wards, where indicated and required.
In addition, to the extent possible, support the medical aspect for the development of new drugs in pediatric oncology, is channeled in the field of financing of MEDICAL RESEARCH supporting projects that can actually lead to significant results in the therapeutic field.
Currently it is possible to determine the molecular mechanism underlying the development of the tumor. So, in consonance with what happens in adults, it is possible to develop personalized therapies that are directed against a specific target, even in children. The future experimental studies will take into account this new approach.